Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandy R Matthews

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Neurocase|January 15, 2013
Frontotemporal dementia in eight Chinese individualsSteven Z Chao, Howard J Rosen, Virgina Azor, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 12, 2013
Depressive symptoms in Chinese-American subjects with cognitive impairmentSteven Z Chao, Brandy R Matthews, Jennifer S Yokoyama, et al.
Aging & Mental Health|January 29, 2011
Implementing innovative models of dementia care: The Healthy Aging Brain CenterMalaz A Boustani, Greg A Sachs, Catherine A Alder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Plos One|March 5, 2015
Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adultsJennifer S Yokoyama, Allen K L Lee, Leonel T Takada, et al.
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
JAMA Neurology|November 26, 2019
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical TrialsAlette M Wessels, Pierre N Tariot, Jennifer A Zimmer, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Geroscience|January 31, 2025
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohortsLuyao Wang, Wenjing Hu, Fan Dong, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neurocase|January 15, 2013
Frontotemporal dementia in eight Chinese individualsSteven Z Chao, Howard J Rosen, Virgina Azor, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 12, 2013
Depressive symptoms in Chinese-American subjects with cognitive impairmentSteven Z Chao, Brandy R Matthews, Jennifer S Yokoyama, et al.
Aging & Mental Health|January 29, 2011
Implementing innovative models of dementia care: The Healthy Aging Brain CenterMalaz A Boustani, Greg A Sachs, Catherine A Alder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Plos One|March 5, 2015
Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adultsJennifer S Yokoyama, Allen K L Lee, Leonel T Takada, et al.
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
JAMA Neurology|November 26, 2019
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical TrialsAlette M Wessels, Pierre N Tariot, Jennifer A Zimmer, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Geroscience|January 31, 2025
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohortsLuyao Wang, Wenjing Hu, Fan Dong, et al.
Pageof 4